Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
Authors
Keywords
Cancer multidrug resistance (MDR), Key regulators, Drug delivery system, Reversal of MDR
Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 37, Issue 1, Pages 4-15
Publisher
Springer Nature
Online
2013-11-22
DOI
10.1007/s12272-013-0276-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer
- (2013) Fan Bai et al. BIOMATERIALS
- The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells
- (2013) Golam Kibria et al. BIOMATERIALS
- TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer Types
- (2012) Amit Chaudhary et al. CANCER CELL
- Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy
- (2012) Kazuhiro Takara et al. JOURNAL OF CONTROLLED RELEASE
- Targeting survivin in cancer: the cell-signalling perspective
- (2011) Jagat R. Kanwar et al. DRUG DISCOVERY TODAY
- Overcoming cellular multidrug resistance using classical nanomedicine formulations
- (2011) Sijumon Kunjachan et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma
- (2011) Bin Zhang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Neuroblastoma-targeted Nanoparticles Entrapping siRNA Specifically Knockdown ALK
- (2011) Daniela Di Paolo et al. MOLECULAR THERAPY
- A Double-modulation Strategy in Cancer Treatment With a Chemotherapeutic Agent and siRNA
- (2011) Kazuya Nakamura et al. MOLECULAR THERAPY
- Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
- (2011) M. Murakami et al. Science Translational Medicine
- Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line
- (2010) Huan Meng et al. ACS Nano
- Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death
- (2010) E Laborde CELL DEATH AND DIFFERENTIATION
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- (2010) Zhiwei Wang et al. DRUG RESISTANCE UPDATES
- Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin
- (2010) Juan Jiang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance
- (2009) Yogesh B. Patil et al. BIOMATERIALS
- Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel
- (2009) Changxing Liu et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance
- (2009) Yogesh Patil et al. JOURNAL OF CONTROLLED RELEASE
- The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice
- (2009) Shan Gao et al. MOLECULAR THERAPY
- Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug
- (2009) Jennifer A MacDiarmid et al. NATURE BIOTECHNOLOGY
- Design considerations for tumour-targeted nanoparticles
- (2009) Hak Soo Choi et al. Nature Nanotechnology
- Polymeric nanoparticles for siRNA delivery and gene silencing
- (2008) Yogesh Patil et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model
- (2008) Amr Abu-Lila et al. JOURNAL OF CONTROLLED RELEASE
- Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer
- (2008) Maha Saad et al. Nanomedicine
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
- Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
- (2008) E. A. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticles for drug delivery in cancer treatment
- (2008) Barbara Haley et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
- (2008) S.-F. Zhou XENOBIOTICA
- MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions
- (2008) Y. Toyoda et al. XENOBIOTICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started